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MicroRNAs (miRNAs) are highly conserved ∼22-mer RNA molecules, encoded by plants and animals that regulate the expression
of genes binding to the 3 -UTR of speciﬁc target mRNAs. The amount of miRNAs in a total RNA sample depends on the
recovery eﬃciency that may be signiﬁcantly aﬀected by the diﬀerent puriﬁcation methods employed. Traditional approaches may
be ineﬃcient at recovering small RNAs, and common spectrophotometric determination is not adequate to quantify selectively
these low molecular weight (LMW) species from total RNA samples. Here, we describe the use of qualitative and quantitative
lab-on-a-chip tools for the analysis of these LMW RNA species. Our data emphasize the close correlation of LMW RNAs with
the expression levels of some miRNAs. We therefore applied our result to the comparison of some miRNA expression proﬁles in
diﬀerent tissues. Finally, the methods we used in this paper allowed us to analyze the eﬃciency of extraction protocols, to study
the small (but signiﬁcant) diﬀerences among various preparations and to allow a proper comparison of some miRNA expression
proﬁles in various tissues.
Copyright © 2009 Andrea Masotti et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Inthelastfewyears,anewclassofhighlyconserved ∼21-mer
non-coding RNAs, microRNAs (miRNAs), has emerged as
an important player in post-transcriptional gene expression
control in diﬀerent physiological and pathological condi-
tions: metabolism, proliferation, cell death, diﬀerentiation
and development, viral infection, and cancer [1–3]. They
speciﬁcally bind the 3 -untranslated regions (3 -UTR) of
target mRNAs, promoting either mRNA degradation or
translation arrest [4–6]. Each miRNA may control the
activity of many genes, and almost 30% of the genome
could be regulated in such a way, which renders these small
molecules as important as the transcription factors [7, 8].
Owingtotheirextremeimportanceasregulators,theiso-
lation and the precise quantiﬁcation of these tiny molecules
are therefore fundamental. As purity and integrity are
essential requirements not only for total RNA but also
for these small species, RNA extraction protocols must
also account for the maximizing of their recovery. Some-
times, the handling and recovery of small RNAs are not
straightforward. Nowadays, it is well established that the
traditional glass-ﬁber total RNA extraction protocol may
be ineﬃcient at recovering small RNAs. In addition, the
common spectrophotometric determination of total RNA
is not adequate to quantify low molecular weight (LMW)
species selectively.
We and other authors found previously that the recovery
of LMW RNA species is signiﬁcantly aﬀected by the speciﬁc
puriﬁcation process [3, 9]. Our results showed that diﬀerent
extraction strategies lead to signiﬁcantly diﬀerent recovery of
LMW species including miRNAs. We also demonstrated that
using the same amount of total RNA (from diﬀerent tissues),
diﬀerent amounts of miRNAs may be obtained. Moreover,
the amount of LMW RNA species does not perfectly parallel
that of miRNAs: even with the same extraction protocol,2 Journal of Biomedicine and Biotechnology
the concentration of miRNAs may diﬀer signiﬁcantly among
various tissues. Nevertheless, this may also be because of a
diﬀerent global expression of miRNA by diﬀerent tissues.
All of these considerations are extremely important when
one compares the relative expression of many miRNAs in
diﬀerent tissues. Commonly, some small non-coding RNAs
(i.e., U6, snoZ30, and others) are used as normalization
controls to compare miRNAs expression in diﬀerent tissues.
The choice of a proper control should be conditioned to
its real “endogenous behavior”, that is, it should have a
constant and equal expression in all tissues. If the amount
of that control small non-coding RNA is diﬀerent, a relative
quantiﬁcation is not feasible. In this latter case, only the
comparison between various miRNAs and the control gene
inthesamespecimen(tissue)ismethodologicallyacceptable.
Therefore, a method allowing a reliable estimation of the
goodness of an endogenous control is highly desirable.
In order to address all of these issues we used a
lab-on-a-chip technology to characterize the LMW RNA
fractions obtained with diﬀerent RNA extraction protocols
and evaluated miRNAs recovery with speciﬁc quantitative
real-time PCR (qRT-PCR).
In this paper we report and discuss the methods that
allowedustoanalyzetheeﬃciencyofextractionprotocols,to
study the small (but signiﬁcant) diﬀerences between various
preparations and to obtain a correct comparison of some
miRNA expression proﬁles in various tissues.
2.MaterialsandMethods
2.1. Total RNA Extraction and Small RNAs Enrichment
Protocols. Total RNA was extracted using three diﬀerent
methods: an acid phenol/guanidine isothiocyanate solution
(TRIzol Reagent, Invitrogen), a glass-ﬁber ﬁltration protocol
(MirVana miRNA Isolation Kit, Ambion) that provides
also a procedure to isolate and enrich low molecular
weight(LMW)RNAsfromhighermolecularweight(HMW)
RNAs,andanothercommonglass-ﬁberpuriﬁcationprotocol
(RNEasy Mini Kit, Qiagen). All extractions were performed
according to manufacturer’s instructions.
2.2. Cell Lines. Three diﬀerent cell lines (HeLa, COS-1
and a lymphoblastoid cell line (LCL) obtained following
an already reported method [10]) were cultured using
standard procedures, trypsinized (if necessary), and pel-
leted by centrifugation. Approximately 107 cells for each
extraction were resuspended in the appropriate lysis solution
contained in the RNA extraction kit and treated according to
manufacturer’s instructions.
2.3. Electrophoresis and RNA Elution from Gel. The integrity
of RNA samples was checked by gel electrophoresis (agarose
1%) stained with ethidium bromide. Gel images were
acquired and analyzed with the Quantity One (software
Ver.2.0, Biorad). Two micrograms of each RNA samples were
resolved into a 15% polyacrylamide TBE-Urea gel and the
image acquired. A second polyacrylamide gel, performed
with the same experimental conditions, was used for RNA
bands extraction. The visible bands were separately excised
usingamodiﬁed“crush-and-soak”method[11].Brieﬂy,each
band was gently disrupted with a pin and incubated in a
soaking solution (0.5M ammonium acetate, 2mM EDTA,
0.1% SDS) for 3 hours at 37
◦C. The mixture was centrifuged
at 14000g for 5 minutes, and the supernatant was collected
in a new tube. The solution was centrifuged at 12000g
for 10 minutes through a YM-50 spin column, washed
with water (3 × 300 μl), and centrifuged at 12000g for 5
minutes. Puriﬁed fractions were collected in new tubes by
inverting the columns and spinning at 1000g for 3 minutes.
These RNA samples were then separately run on the Agilent
Bioanalyzer.
2.4. Agilent 2100 Bioanalyzer Chip Preparation. Total RNA
samples were analyzed with the Total RNA 6000 Nano
Kit (Vers. II), speciﬁcally optimized for total RNA analysis
with the Agilent 2100 Bioanalyzer. RNA samples obtained
after extraction from polyacrylamide gel were run with the
same kit. For miRNA quantiﬁcation we used the dedicated
Small RNA kit. The instrument uses ﬂuorescence detection,
monitoring the emission between 670nm and 700nm. The
runwasperformedaccordingtomanufacturer’sinstructions.
Electropherograms were analyzed using the Agilent 2100
ExpertB.02.06softwarethatincludesdatacollection,presen-
tation, and interpretation functions.
2.5. Real-Time PCR. For the small RNAs recovery eﬃciency
evaluation of diﬀerent extraction procedures, hsa-miR-21
and small nucleolar Z30 (snoZ30) were assayed by Real-
Time PCR (TaqMan, Applied Biosystems), according to
manufacturer’s instructions [12]. For the analysis of miRNA
expression in diﬀerent tissues, three miRNAs (hsa-miR-26a,
hsa-miR-26b, and hsa-miR-134) and two controls (U6 and
snoZ30) were arbitrarily chosen as model miRNAs. A panel
of ﬁve tissues (brain, skeletal muscle, heart, liver, and uterus)
was chosen for evaluation, and the corresponding total RNA
(Clontech, BD Biosciences) was analyzed with Agilent 2100
Bioanalyzer. Brieﬂy, from ﬁve to ten nanograms of each
RNA samples were retrotranscribed to cDNA using the
High-Capacity cDNA Archive Kit (Applied Biosystems) with
speciﬁc primers. The principle of TaqMan MicroRNA Assays
is a speciﬁc stem-loop reverse transcription (RT) primer.
The short length of mature miRNAs (∼22nt) prohibits
conventional design of a random-primed RT step followed
by a speciﬁc real-time assay. In the former case, the resulting
RT amplicon is a suitable template for standard real-
time PCR with TaqMan assays. Reactions were performed
incubating samples for 30 minutes at 16
◦C, 30 minutes at
42
◦C, 5 minutes at 85
◦C ,a n dﬁ n a l l yc o o l e do ni c e .P C R
productswereassayedwithspeciﬁcprobesusingtheTaqMan
Universal PCR Master Mix, No AmpErase UNG (Applied
Biosystems) following the manufacturer’s protocol. PCR
reactions were performed incubating samples for 10 minutes
at 95
◦C, then for 15 seconds at 95
◦C and 60 seconds at 60
◦C
for 45 cycles by means of ABI PRISM 7900HT Sequence
DetectionSystem.DatawereanalyzedusingtheSDSsoftware
(Ver. 2.1).Journal of Biomedicine and Biotechnology 3
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Figure 1: Gel electrophoresis (agarose 1% stained with ethidium
bromide) of RNA samples (from COS-1) extracted with TRIzol
reagent (lane 1), MirVana kit (lane 2), RNEasy kit (lane 3), and
LMW RNA fraction enriched with MirVana kit (lane 4).
2.6. Deconvolution with PeakFit Software. The early elec-
tropherogram region (from 23 to 29 seconds), obtained
from LCL RNA sample extracted with TRIzol reagent, was
exported in ASCII format with the Agilent 2100 Expert
B.02.06 and imported in PeakFit V.4.12. The curve was
automatically ﬁtted using the least-squares method. Data
were further adjusted using the Savitzky-Golay smoothing
algorithm. The overall model was ﬁtted with chromato-
graphic Gaussian curves of variable amplitudes. The ﬁtting
procedure was iterated until a constant r2 value (r2 =
0.998693) was obtained.
3. Results
3.1. The Recovery of Low Molecular Weight (LMW) RNAs
Is Aﬀe c t e db yD i ﬀerent Extraction Protocols. RNA samples
extracted from HeLa, COS-1, and LCL were run on agarose
gel to visualize the diﬀerences between various extraction
methods. COS-1 RNA samples, extracted with TRIzol
reagent and MirVana kit, clearly showed the High Molecular
Weight(HMW)28Sand18SrRNAbands,whileLMWRNAs
are visualized as faint, smeary bands (Figure 1,l a n e s1a n d2 ,
resp.). COS-1 extracted with RNeasy kit displayed only the
HMW RNA bands (28S and 18S) (Figure 1,l a n e3 ) ,w h i l e
the enriched LMW fraction obtained with MirVana kit is
clearly displayed in the lowest part of the gel (Figure 1,l a n e
4). Similar results (not shown) were also obtained with the
other cell lines.
The same samples were also checked with Agilent 2100
Bioanalyzer which is one of the most versatile microﬂuidics-
based platforms for the analysis of DNA, RNA, proteins and
cells. In all electropherograms the 28S and 18S RNAs are
represented on the right side (Figure 2), and the smaller
species (LMW RNAs) are present at a very low concentration
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Figure 2: Agilent 2100 Bioanalyzer electropherogram proﬁles of
total RNA samples (HeLa cells) extracted with TRIzol reagent
(green), MirVana kit (blue), and RNEasy kit (red). Inbox: magni-
ﬁcation of small RNA proﬁles for the three samples (between 23
and 29 seconds).
and distinguishable on the left side of the proﬁle (see the
magniﬁcation of the LMW RNAs region in Figure 2). In
the electropherogram, all samples present a similar HMW
proﬁle region, but the major diﬀerences are recognizable in
the LMW region. While total RNA recovery is quite good,
and similar for the three protocols (> 1.2μg/μl), the LMW
fractions are substantially diﬀerent (Table 1). In particular,
TRIzol reagent allowed the highest LMW RNA recovery
(22%–34% of total RNA), while RNEasy Mini Kit the
lowest (2.5%–3%). MirVana miRNA Isolation Kit gives good
yields for LMW RNA species (16%–19%) even before the
enrichment step. While LMW RNA species extracted with
TRIzol and MirVana have comparable proﬁles (Figure 2);
RNEasy kit retains only one RNA peak in comparable
concentrations to the others (peak a in the magniﬁcation
of Figure 2). Therefore, the lab-on-a-chip analysis is a useful
tool to quantify precisely the amount of LMW RNAs of
samples extracted with diﬀerent protocols.
3.2. Low Molecular Weight (LMW) RNAs Characterization.
T o t a lR N A sf r o mL C Le x t r a c t e dw i t hT R I z o lr e a g e n t ,a n d
RNEasy kit and enriched with MirVana kit were loaded on4 Journal of Biomedicine and Biotechnology
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Figure 3: (a) Gel electrophoresis (polyacrylamide 15% stained with ethidium bromide) of LMW RNA samples (LCL) extracted with
TRIzol reagent (lane 1), RNEasy kit (lane 2), and small RNA fraction enriched with MirVana kit (lane 3). LMW proﬁle obtained with
MirVana kit extraction is similar to that obtained with TRIzol reagent which is not shown for clarity. (b) Agilent 2100 Bioanalyzer
electropherogram proﬁle of LMW RNAs (LCL) extracted with TRIzol (black) superimposed on 5.8S (red), 5S (green), and tRNA (blue)
bands eluted from polyacrylamide gel. (c) Lymphoblastoid (LCL) LMW RNA proﬁle obtained after plotting the exported raw data from
Agilent electropherogram ( ) together with the PeakFit ﬁtted curve (solid line) and the component peak functions. Seven peaks below the
LMW RNA proﬁle were ﬁtted by the software (r2 = 0.998693).
ap o l y a c r y l a m i d eg e l( Figure 3(a)) to analyze the diﬀerences
between various extraction protocols. All the RNA bands
were cut out from the gel, and the RNA was extracted
as described. Each species coming from excised bands was
run on Bioanalyzer, and the corresponding electrophero-
grams (Figure 3(b)) were superimposed on the large and
unresolved LMW RNA proﬁle (black line). This allowed us
to localize unambiguously and identify precisely each RNA
species previously identiﬁed on polyacrylamide gel.
T h ee l e c t r o p h e r o g r a mp r o ﬁ l ei nt h eL M WR N A sr e g i o n
is made of several peaks (Figure 3(b)), the greatest part
belonging to the 5.8S rRNA (red line), the 5S rRNA (green
line), and the tRNAs fractions (blue line). In order to obtain
the principal number of peaks under the curve, PeakFit
software was used for the deconvolution of the LMW RNA
region. Seven peaks underlying the LMW RNA proﬁle were
obtained with a good ﬁt (r2 = 0.998693). The upper
part of Figure 3(c) reports raw data ( ) together with the
ﬁtted curve (solid line) and the calculated baseline, while
the lower part of Figure 3(c) shows the component peak
functions. Calculated peak-peaking (expressed in bp) is
also reported (Figure 3(c)). Three of the calculated peaks
centered at 145bp (26.89 seconds), 131bp (26.33 seconds),
and104bp(25.24seconds)arelocatedinthecorrespondenceJournal of Biomedicine and Biotechnology 5
Table 1: Low molecular weight (LMW) RNA mean concentration (% with respect to total RNA) for HeLa, COS-1 and LCL extracted with
diﬀerent RNA extraction protocols evaluated with Agilent 2100 Bioanalyzer. Standard deviations of at least three independent extractions
are reported in parentheses.
LMW RNA Mean concentration (%)
Extraction method (total RNA) HeLa COS-1 LCL
TRIzol reagent (acid phenol/guanidine isothiocyanate) 24 (±3) 34 (±2) 22 (±3)
MirVana kit 16 (±1.5) 19 (±1) 19 (±1)
RNEasy kit 2.5 (±0.5) 3 (±0.5) 3 (±0.5)
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Figure 4: Small nucleolar Z30 real-time PCR assay (two replicas) of RNA samples (LCL) obtained starting from 10ng of total RNA samples
(a) and from 10ng of LMW RNA (b) extracted with diﬀerent protocols. In the latter case Ct values of samples from diﬀerent extractions are
more reproducible, indicating a strict correlation between the amount of miRNAs and the LMW RNA fraction.
of 5.8S, 5S, and tRNA peaks, respectively. Another less
intense peak is located at 114bp (25.83 seconds) and may
be described as a further tRNA peak. Other peaks found
at 171bp (27.78 seconds), 89bp (24.84 seconds) and 65bp
(24.31 seconds) might belong to other LMW RNA species,
such as smaller tRNAs, pre-miRNAs, and small nuclear or
nucleolar RNAs. These small peaks are diﬃcult to extract
from polyacrylamide gel owing to their low abundance, and
therefore it was not possible to run them on the chip.
Therefore, determination of small RNA species by Bio-
analyzer (Table 1) and by polyacrylamide gel electrophoresis
(Figure 3(a)) showed that the LMW RNA samples signiﬁ-
cantly diﬀer from each other. This could reasonably pertain
also to the miRNAs fraction.
3.3. MicroRNAs Amount Correlates with the LMW RNA Frac-
tion. In order to quantify miRNAs extracted with diﬀerent
protocols and to study the correlation between LMW RNAs
and miRNAs, we carried out a TaqMan quantitative assay
for two representative small RNAs: a control non-coding
RNA (snoZ30) and a miRNA (hsa-miR-21). A target-speciﬁc
stem-loop adapter technology was employed to obtain the
corresponding cDNA [12].
We started the RT reaction with 10ng of total RNA from
each sample and quantiﬁed the absolute expression level of
each miRNAs through the analysis of cycle threshold (Ct)
values. Ct is the PCR cycle at which the sample reaches the
level of detection above the background. LCL RNA samples
extracted with diﬀerent protocols showed diﬀerent Ct values
for snoZ30 (Figure 4(a)) and for miR-21. A similar behavior
was also obtained by using HeLa and COS-1 cell lines with
both probes (data not shown).
Then, we repeated the RT reaction using 10ng of LMW
RNA calculated from the Bioanalyzer electropherogram. As6 Journal of Biomedicine and Biotechnology
Table 2:Real-timePCRdataobtainedforHeLaandLCLwerecomparedcalculatingtheΔCtdiﬀerencesbetweenCt(10ngoftotalRNA)and
Ct (10ng of LMW RNA) values for miR-21 and snoZ30. Standard deviations of at least three independent assays are reported in parentheses.
LMW RNA concentrations (%) calculated using the formula 2−ΔCt·1 0 0a r ea l s or e p o r t e dw h e r eΔCt are referred to snoZ30 values. Standard
deviations of at least three independent assays are reported in parentheses.
ΔCt (total RNA-LMW RNA) Calculated LMW RNA (%) (2−ΔCt(snoZ30) ·100)
Cell Type Extraction Method miR-21 snoZ30
HeLa TRIzol reagent 1.8 (2) 2.1 (1) 23 (±2)
MirVana kit 2.5 (1) 2.9 (1) 13 (±1)
RNEasy kit 3.5 (4) 5.1 (3) 3 (±0.5)
LCL TRIzol reagent 2.3 (1) 2.4 (1) 19 (±1)
MirVana kit 2.2 (1) 2.1 (4) 23 (±5)
RNEasy kit 4.2 (2) 4.6 (4) 4 (±1)
expected, using the same LMW RNA amount similar Ct
values both for miR-21 and snoZ30 between the various
samples were obtained (Figure 4(b)). This demonstrates that
the amount of miR-21 and snoZ30 correlates only to the
LMW RNA fraction and not to total RNA amount. In fact,
Figure 4(a) clearly shows that using the same amount of total
RNA diﬀerent Ct values may be obtained.
Ct diﬀerences (ΔCt)b e t w e e nt o t a lR N Aa n dL M W
RNA Ct values for each extraction protocol and for each
cell line are very similar both for hsa-miR-21 and snoZ30
(Table 2). This demonstrates that ΔCt diﬀerences parallel
the amount of input RNA that is ultimately linked to the
amount extracted by various protocols. Table 2 reports also
the calculated LMW RNA concentration (expressed in %)
calculated from ΔCt values applying the formula 2−ΔCt.
MiRNA concentrations calculated from real-time assays
are, as expected, in perfect agreement with LMW RNAs
concentrations evaluated with the lab-on-a-chip technology.
3.4. Diﬀerent Tissues Express Diﬀerent Amounts of Small- and
MicroRNAs. Here,weshowedthatLMWRNAsandmiRNAs
amount are closely correlated. Then, we asked if diﬀerent
tissues might also express diﬀerent amounts of LMW and
miRNAs and if it might be possible to quantify them indi-
vidually with lab-on-a-chip technology. For this reason we
selected ﬁve commercial RNA samples from diﬀerent tissues
extractedwiththesameprotocol(accordingtomanufacturer
information). Total RNAs from brain, skeletal muscle, heart,
liver, and uterus were run on RNA 6000 Nano kit to
quantify the total and the LMW RNA fractions. Total RNA
concentrations were quite homogeneous and resulted: brain
(1159ng/μL) > heart (1106ng/μL) > uterus (1080ng/μL) >
liver (963ng/μL) > skeletal muscle (890ng/μL). These values
areingoodagreementwiththenominalmanufacturer’scon-
centration of 1000ng/μL. For all samples the concentration
of LMW RNA fraction was quite homogeneous and varied
in the order: liver (43ng/μL) > brain (29ng/μL) > heart
(26ng/μL) > uterus (25ng/μL) > skeletal muscle (23ng/μL).
Electropherograms of LMW RNAs of diﬀerent tissues are
displayed in Figure 5(a). Calculating the percentage of LMW
RNAs with respect to the whole total RNA amount we found
the following: liver (4.4%) > skeletal muscle (2.6%) > brain
(2.5%) > heart (2.3%) > uterus (2.3%). Only some minor
diﬀerences may be observed among various tissues. Given
that the extraction protocol employed by the manufacturer
was the same for all samples, we could hypothesize that
the only observed diﬀerence for liver might depend on the
diﬀerent global expression of small RNAs in this tissue.
To evaluate if the diﬀerence in LMW RNA amount may
also pertain to the miRNA fraction, we ran the total RNA
samples on Agilent Small RNA kit, speciﬁcally designed for
theevaluationofmiRNAs.Figure 5(b)showsamagniﬁcation
of the electropherogram proﬁle obtained by running total
RNA samples from diﬀerent tissues. The displayed region
(from 35 to 45 seconds) is speciﬁc to the miRNA region (as
indicatedbythemanufacturer).MiRNAconcentrationswere
liver (700pg/μL) > brain (510pg/μL) > uterus (404pg/μL) >
heart (226pg/μL) > skeletal muscle (71pg/μL). The miRNA
concentration, expressed in percentage, respect to LMW
RNAs resulted brain (1.7%) > liver (1.6%) = uterus (1.6%)
> heart (0.9%) > skeletal muscle (0.3%). From this lab-on-
a-chip quantiﬁcation it was possible to conclude that the
miRNAs amount does not parallel that of LMW RNAs in
the same tissue. Moreover, the variation is greater than that
displayed by LMW RNAs among diﬀerent tissues. Again,
assuming that the extraction eﬃciency is the same for all
samples,theobserveddiﬀerencesareonlyduetothediﬀerent
global expression of miRNAs in these tissues.
3.5. Evaluation of Endogenous Controls’ Reliability and Their
Use for Expression Proﬁle Comparison. The Small RNA kit,
speciﬁcally designed for the identiﬁcation and quantiﬁcation
of miRNA species, allowed us to know the exact amount of
miRNAs present in the samples used for retrotranscription
(RT)reactions.Thisinformationisuseful,sincetheCtvalues
obtained from real-time assays are directly proportional
to the amount of miRNAs. In fact, the Ct diﬀerences
observed for the same miRNA in diﬀerent tissues may be due
essentially (1) to a real diﬀerence between diﬀerent samples
and/or (2) to a diﬀerent sample dilution that generates a
shiftinCtabsolutevalues.Toeliminatethedilutionproblem,
that occurs when absolute quantiﬁcation is performed, a
relative quantiﬁcation with respect to an endogenous control
is commonly followed. In fact, the endogenous control mustJournal of Biomedicine and Biotechnology 7
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Figure 5: (a) Electropherogram proﬁle of LMW RNA species of ﬁve diﬀerent tissues (brain, skeletal muscle, heart, liver, and uterus). (b)
Electropherogram proﬁle of miRNA species of the same tissues.
haveaconstantexpressioninallsamples,andhenceitmaybe
used to normalize the expression of the other miRNAs. For
a methodologically correct comparison, however, one must
be conﬁdent that the control (i.e., nuclear and/or nucleolar
smallRNAs)reallydoeshaveaconstantexpressioninconsid-
ered samples. The lab-on-a-chip technology that we used is
abletogiveanestimateofthisvariationandlettheresearcher
choose the right endogenous control (the one that does not
signiﬁcantlyvary)fromanadequateselection.Therefore,this
validation ensures that the miRNA expression comparison
among considered samples is methodologically correct.
The expression of three miRNAs (hsa-miR-26a, hsa-
miR-26b, and hsa-miR-134) and two small RNAs (U6 and
snoZ30) from the same ﬁve tissues analyzed before, was
assayed with real-time PCR. According to the manufacturer’s
suggestion, we started the RT reactions with 5ng of total
RNA. Cycle threshold values for all tissues are reported in
Table 3. As expected, diﬀerent Ct values for endogenous
and other miRNAs were obtained. These values reﬂect the
absolute concentrationsof these miRNAs in various samples.
Since most studies aim to discover diﬀerences in expression
levels of miRNAs and not absolute levels of expression, the
use of an endogenous control is needed. In order to assess if
the diﬀerences in Ct values of the controls we used (U6 and
snoZ30) are because of a diﬀerent starting concentration or a
real diﬀerential expression, we corrected the obtained values
by taking into account the concentration of miRNAs previ-
ously obtained with the lab-on-a-chip technology. Hence, we
considered that for double the concentration a correction of
one Ct value should be applied. This preliminary correction
eliminated the intrinsic variability owing to diﬀerent sample
concentrations and allowed us to estimate the reliability
of the selected endogenous controls. We observed slight
variation for Ct values of U6 (Average Ct = 33.5±0.8) while
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Figure 6: Corrected comparison of the relative expression of a
miRNA selection in ﬁve diﬀerent tissues (brain, skeletal muscle,
heart, liver, and uterus) with respect to the U6 endogenous control.
snoZ30 displayed a higher variability (Average Ct = 34.1 ±
1.1) even after the applied correction. This means that U6
is constitutively expressed, at least in these tissues. Certainly,
thelowertheCtdiﬀerenceis,themorereliablearetheresults.
To facilitate this, more lab-on-a-chip quantiﬁcations and real
time assays are needed.
Therefore, we concluded that U6 is a more reliable
endogenous control than snoZ30 for miRNA expression
proﬁle comparison in the analyzed tissues. The miRNA
expression proﬁle comparison is reported in Figure 6.8 Journal of Biomedicine and Biotechnology
Table 3: List of miRNAs expressed in diﬀerent tissues with their
average Ct values. Corrected Ct values represent the correction
madeaftertheprecisequantiﬁcationofmiRNAspecieswiththelab-
on-a-chiptechnology.
MicroRNA Average Ct Corrected Ct
Brain
U6 34.16 33.70
snoZ30 35.98 35.52
miR-26a 29.77 29.31
miR-26b 33.45 32.99
miR-134 33.67 33.21
Liver
U6 32.37 32.37
snoZ30 32.85 32.85
miR-26a 28.90 28.90
miR-26b 30.70 30.70
miR-134 37.30 37.30
Muscle
U6 36.55 33.24
snoZ30 37.35 34.04
miR-26a 31.74 28.43
miR-26b 34.40 31.09
miR-134 38.23 34.92
Uterus
U6 34.61 33.81
snoZ30 34.12 33.32
miR-26a 30.67 29.87
miR-26b 33.28 32.48
miR-134 38.77 37.97
Heart
U6 36.15 34.52
snoZ30 36.28 34.65
miR-26a 32.60 30.97
miR-26b 36.21 34.58
miR-134 37.93 36.30
We then compared our data with those reported in
literature [13]. Figure 7 shows the expression values of hsa-
miR-26a, hsa-miR-26b and hsa-miR-134 compared with the
expression values of some tissue-speciﬁc miRNAs (miR-1 for
heart and muscle, miR-122a for liver, miR-124a for brain).
Expression values of miRNAs are expressed as copies per ng
of RNA.
4. Discussion
One of the most diﬃcult problems with miRNAs experi-
mental studies concerns the eﬃciency of their quantitative
and qualitative recovery after total RNA extraction from cells
or tissues. In some cases, traditional total RNA extraction
protocols are not eﬃcient methods for extracting both high
molecularweight(HMW)andlowmolecularweight(LMW)
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Figure 7:Expressionvaluesofhsa-miR-26a,hsa-miR-26b,andhsa-
miR-134 reported in literature [13] compared with the expression
values of tissue-speciﬁc miRNAs.
RNAs. Moreover, conventional quantiﬁcation methods (i.e.,
spectrophotometric measurements) giving an overall quan-
tiﬁcation of total RNA concentration are therefore inad-
equate for these small RNA species. Northern blotting is
the only current viable technique to visualize and evaluate
small RNA molecules, particularly miRNAs. However, their
low abundance sometimes prevents the use of such tech-
niques. On the other hand, the lab-on-a-chip technology we
employed is an alternative and valuable tool for the precise
quantiﬁcation of small RNAs and miRNAs present in total
RNA samples.
In this work, to characterize in detail all the LMW RNA
species visible in the Bioanalyzer electropherogram (5.8S, 5S,
tRNAs, etc.), we ran RNA samples on polyacrylamide gels
to clearly separate each of the predominant species present
in the small RNA region (Figure 3(a)). We also optimized
an elution protocol from excised polyacrylamide bands after
gel electrophoresis. Then, we monitored the eluted fractions
by means of a lab-on-a-chip technology that is, at present,
the only technique that allows for the comparison of small
RNA proﬁles and the exact quantiﬁcation of these species
(Figure 3(b)). Several other species were present under the
peak of LMW RNAs, even if it was not possible to distinguish
each of them. For these reasons, we applied a mathematical
algorithm (the Fourier transform) for the deconvolution
of the proﬁle coming from the Bioanalyzer into diﬀerent
Gaussian peaks. After the ﬁtting procedure, we obtained
a mathematical model comprising seven peaks that deﬁne
the overall proﬁle (Figure3(c)) . These peaks range from
a minimum of 65bp to a maximum of 171bp, which is
well in agreement with the results obtained with Agilent
automatic peak-peaking that relies on the comparison of
RNA species with an RNA ladder included in the running
buﬀer. Interestingly, after this procedure was performedJournal of Biomedicine and Biotechnology 9
some other non-assigned bands remained undetermined.
These species may belong to smaller RNA species like
miRNAs. To clarify this, the Small RNA kit, speciﬁcally
designedfortheanalysisofmiRNAspecies,wasusedtostudy
these unidentiﬁed species in more detail.
We initially compared the three commonest RNA extrac-
tion protocols, the classic acid phenol/guanidine isothio-
cyanate solution, and two glass ﬁber ﬁltration protocols to
examine and quantify the recovery of HMW and LMW RNA
species. The acid phenol/guanidine isothiocyanate solution
(Table 1) maximized not only the recovery of HMW RNA
fractions but also the LMW RNAs (from 22% to 36%), as
previously observed [3]. Then, we assessed by real-time PCR
how signiﬁcantly aﬀected the recovery of miRNA species was
as a function of the total RNA extraction protocol used.
The expression levels of a miRNA (hsa-miR-21) and a small
nucleolar RNA (snoZ30) were evaluated by real-time PCR
speciﬁc assays [12]. This technique represents an eﬀective
alternative to Northern blotting for miRNA detection and
quantiﬁcation. Real-time quantiﬁcation results (Table 2)
demonstrated that the amount of miRNAs correlates better
with the amount of LMW RNAs than with total RNA.
Another aspect that we critically analyzed concerned the
correlation between LMW RNA species and miRNAs. The
presenceofLMWRNAsis notalwaysdirectlycorrelatedwith
that of miRNAs. In fact, we proved that even with the same
extraction protocol the concentration of miRNAs may diﬀer
considerably between various preparations (i.e., extraction
from diﬀerent tissues).
As a potential application of our results, we applied our
ﬁndings to the comparison of some miRNA expression in
diﬀerent tissues. We assessed the expression of hsa-miR-26a,
hsa-miR-26b, and has-miR-134 as model miRNAs and two
small RNAs (U6 and snoZ30) as controls. The expression
proﬁle comparison is correct only if we assume that the
endogenous control (U6 or others) has a constant and
equal expression in all the considered tissues. The lab-on-
a-chip technology we used allowed precise quantiﬁcation of
input miRNAs, ultimately leading to a ﬁne correction of
real-time PCR Ct data for eventual variations. Therefore,
we obtained a reliable and correct estimate of the relative
quantitiesofmiRNAspresentinvarioustissues.Surprisingly,
the expression of miR-26a was the highest of all the miRNAs
in all the tissues considered (fold change > 10 with respect to
U6). Although our data are in good agreement with those
reported in literature [13]( Figure 7), the high expression
values found for miR-26a will deserve future investigations.
However, the expression values of miR-26a reported in
literature [13] are also very high (and higher than those
of miR-26b) and above the values of those tissue-speciﬁc
miRNAs considered as highly expressed (i.e., miR-1 for
muscle, miR-124a for brain, and miR-122a for liver) (see
Figure 7).
In conclusion, all the methods we used in this paper
allowed us to study accurately the eﬃciency of extraction
protocols, analyze the small (but signiﬁcant) diﬀerences
between various preparations, and suggest a methodologi-
cally correct method for the comparison of miRNA expres-
sion proﬁles in various tissues.
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